Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Aug 11;21(6):1571–1580.e7. doi: 10.1016/j.cgh.2022.08.001

Table 1:

Demographic and social characteristics of patients, by group allocation

Variable All Patients
(N=9635)
Any Psychotherapy
(N=3544)
No Psychotherapy
(N=6091)
P value
Age, Mean (SD) 54.8 (16.5) 51.3 (16.0) 56.8 (16.5) <0.001
Female Sex, N (%) 3814 (39.6) 1682 (47.5) 2132 (35.0) <0.001
Male Sex, N (%) 5821 (60.4) 1862 (52.5) 3959 (65.0) <0.001
Asian, N (%) 84 (0.9) 36 (1.0) 48 (0.8) 0.26
Black, N (%) 720 (7.5) 224 (6.3) 496 (8.1) 0.001
White, N (%) 8045 (83.4) 2975 (83.9) 5070 (83.2) 0.36
Other, N (%) 332 (3.4) 134 (3.8) 198 (3.3) 0.18
Unknown, N (%) 454 (4.7) 175 (4.9) 279 (4.6) 0.43
Hispanic, N (%) 320 (3.3) 110 (3.1) 210 (3.4) 0.38
BMI, Mean (SD) 28.7 (6.7) 28.8 (6.3) 28.7 (7.0) 0.63
Viral Hepatitis, N (%) 1204 (12.4) 484 (13.6) 720 (11.8) 0.009
Homeless, N (%) 978 (10.1) 463 (13.0) 515 (8.5) <0.001
MAT, N (%) 3906 (40.5) 1949 (54.9) 1957 (32.1) <0.001
Psychiatric Disorder, N (%) 8227 (85.3) 3500 (98.7) 4727 (77.6) <0.001
Nicotine Dependence, N (%) 4260 (44.2) 1777 (50.1) 2483 (40.7) <0.001
Non-alcohol SUD, N (%) 3532 (36.6) 1860 (52.4) 1672 (27.4) <0.001

SD: standard deviation, N: number of patients, BMI: body mass index, MAT: medical addiction therapy, SUD: substance use disorder

p values for categorical variables refer to the results of a Fisher exact test comparing patients receiving any psychotherapy to those not receiving psychotherapy. For continuous variables, they refer to the results of a t test with Welch correction.

Non-alcohol SUD refers to one of: cannabis, cocaine, other stimulant, opioid, inhalant, or sedative use disorder.